Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,142 | 51,195 | 46,764 | 44,518 | 59,333 |
| Marketable Securities | 54,173 | 50,512 | 42,952 | 22,183 | 4,074 |
| Receivables | 17,724 | 15,642 | 14,828 | 14,024 | 14,454 |
| Inventories | 26,571 | 25,025 | 24,013 | 24,329 | 24,113 |
| TOTAL | $153,328 | $145,082 | $131,247 | $107,952 | $104,491 |
| Non-Current Assets | |||||
| PPE Net | 16,424 | 11,273 | 11,436 | 11,662 | 11,567 |
| Investments And Advances | 31,659 | 37,613 | 42,657 | 64,335 | 58,913 |
| Intangibles | 33,948 | 31,749 | 31,016 | 31,525 | 0 |
| Other Non-Current Assets | 7,214 | 8,673 | 10,411 | 12,114 | 31,585 |
| TOTAL | $89,245 | $89,308 | $95,520 | $119,636 | $102,065 |
| Total Assets | $242,573 | $234,390 | $226,767 | $227,588 | $206,556 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 3,576 | N/A |
| Accounts payable and accrued liabilities | 3,737 | 2,989 | 2,995 | 2,924 | 3,698 |
| Accrued Expenses | 9,567 | 5,441 | 4,920 | 5,550 | 6,619 |
| Other current liabilities | 4,639 | 4,062 | 3,736 | 4,843 | 4,080 |
| TOTAL | $21,018 | $15,124 | $14,086 | $19,146 | $17,036 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,324 | 929 | 868 | 772 | 1,018 |
| Other Non-Current Liabilities | 512 | 516 | 442 | 437 | 375 |
| TOTAL | $3,949 | $4,118 | $4,218 | $4,386 | $6,955 |
| Total Liabilities | $24,967 | $19,242 | $18,304 | $23,532 | $23,991 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,132 | 53,997 | 53,861 | 52,536 | 51,377 |
| Common Shares | 270 | 269 | 263 | 261 | 256 |
| Retained earnings | -69,697 | -71,260 | -75,509 | -79,600 | -97,226 |
| Other shareholders' equity | 1,067 | 590 | -1,297 | -626 | -327 |
| TOTAL | $217,606 | $215,148 | $208,463 | $204,056 | $182,565 |
| Total Liabilities And Equity | $242,573 | $234,390 | $226,767 | $227,588 | $206,556 |